By Meghan Hall The life science industry continues to be a major driver of commercial real estate in the San Francisco Bay Area, and assets are often quickly snapped up by eager investors. In a deal that kicked off the month of March with a bang, Stockbridge Capital Group purchased an Alameda asset for $158.9 […]
Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.
Signup for news and special announcements!
You have successfully joined our subscriber list.
A San Francisco investor less than two years old has bought most...
ByThe RegistryNovember 4, 2026A 9.93-acre multi-tenant industrial property on Vacaville's I-80 corridor, whose ownership filled...
ByThe RegistryNovember 4, 2026California voters approved Proposition 1, authorizing $11.25 billion in state bonds for...
ByThe RegistryNovember 4, 2026San Francisco tenants have absorbed 3.67 million square feet of office space...
ByThe RegistryNovember 4, 2026